| Reduced Risk Status: |
THIS AI HAS BEEN CLASSIFIED AS RR FOR ONE OR MORE FOOD USES.
|
| IPM Compatibility: |
PER REQUESTOR, VERY GOOD FIT; ACEQUINOCYL PLAYS A SIGNIFICANT ROLE IN EXISTING HOPS IPM PROGRAMS
|
| Reasons for need: |
SPIDER MITES; THE ADDITIONAL RESIDUE TRIALS WILL ALLOW HOPS MRLS TO BE CONSIDERED FOR A BROADER RANGE OF KEY EXPORT MARKETS
|
| Requesting State(s): |
WA:Elliot, M* ;
|
| PCR Use Pattern: |
KANEMITE AT 0.3 LB AI/A, 2 APPL, 21-DAY INTERVAL, 7-DAY PHI, APPLIED FOLIARLY USING A MINIMUM OF 80 GPA
|
| EPA Default Residue Trials: |
5/11/12-4
|
| IR-4 Residue Trial Plan: |
5/11/12-4
|
| Residue Protocol Use Pattern: |
USE THE KANEMITE 15 SC PRODUCT (1.25 LB AI/GAL OF ACTIVE INGREDIENT ACEQUINOCYL); MAKE 2 FOLIAR APPLIC OF 0.3 LB AI/A IN 80-200 GPA, AT A 21-DAY INTERVAL AND 7-DAY PHI; ALL APPLIC SHALL INCLUDE A LABELED RATE OF AN ADJUVANT
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
This study is in the process of being cancelled because the GLP analysis of the test substance revealed a deficient amount of the active ingredient in the material sent to the field test sites:11/23/sb; the status of "complete with ongoing trials" is now being changed to "mfg obj" as UPL plans to support the Codex MRL using their existing data. The study is in the process of being cancelled and the status will be updated again once cancelled:12/23/sb; Mfg obj updated to Study Canceled by IR-4 eff 5/21/24:05/24/sb
|
| International Status: |
|
| Archive Location: |
54-2, 55-3
|
| QA Archive: |
|